CClinicalTrials.gg
RecruitingNCT07421336Updated Mar 4, 2026

Effects of Laughter Yoga in Older Adults

An interventional study of Lughter yoga in Laughter Yoga, sponsored by Ankara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 60 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-04.

Sponsored by Ankara University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Dec 2025; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
60 Years to 90 Years
Sex
All
01

Study summary

The purpose of this study is to observe the effects of laughter yoga on psychological well-being and depressive symptoms in older adults.

Read the detailed description

Laughter yoga is a non-invasive and non-pharmacological intervention method that combines laughter, yoga and breathing techniques. Laughter yoga, which is accepted as a nursing intervention, has become one of the increasingly used methods among complementary health approaches. The aim of this study is to examine the effects of laughter yoga on psychological well-being and depressive symptoms in older adults. The study was planned as a randomized controlled experimental study with pretest-posttest measurements. The research will be conducted with a total of 70 older adults, 35 experimental and 35 control. The data of the study will be collected using the Introductory Information Form, Geriatric Depression Scale-15 (Short Form) and Psychological Well-Being Scale in the Elderly. The data will be analyzed with the SPSS package program.

02

Conditions studied

  • Laughter Yoga

Browse trials for

Keywords

  • laughter yoga
  • older adults
  • psychlogical well-being
  • depressive symptoms
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 70 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Ankara University is the lead sponsor of 312 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Not having a diagnosis of neurocognitive disorders such as Alzheimer's or dementia.
  • Not having a diagnosis of mental disorder
  • Being 65 years and older
  • Literacy
  • Not having communication problems that would prevent answering the data collection form.
  • Volunteering to participate in the research

Exclusion criteria

Exclusion Criteria:

  • Having a diagnosis of neurocognitive disorders such as Alzheimer's or dementia.
  • Having a diagnosis of mental disorder
  • Being under 60 years of age
  • Illiteracy
  • Having communication problems that prevent one from answering the data collection form.
  • Not volunteering to participate in the research.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Laughter yoga

    This group will undergo laughter yoga intervention.

    Other: Lughter yoga

  • No intervention
    control group

    No intervention will be made against this group.

Interventions

  • OtherLughter yoga

    The study divided the intervention and control groups. Participants in the intervention group will be given laughter yoga. Data collection tools will be administered as pre-tests to both the intervention and control groups. After the laughter yoga sessions are completed, data collection tools will be administered again as post-tests to both groups.

06

What researchers measure

Primary outcomes

  1. geriatric depression scale - short form

    The scale consists of fifteen questions, which are answered with "yes/no". The scale results indicate that a score of 0-4 does not indicate depression, 5-8 indicates mild depression, 9-11 indicates moderate depression, and 12-15 indicates severe depression.

    Time frame: eight weeks

  2. Psychological Well-being Scale for the Elderly (YPİOÖ)

    The scale, consisting of fifteen questions, is a 5-point Likert type. 1 point is answered as "strongly disagree" and 5 points as "strongly agree". Items 8 and 13 are reverse-scored. The minimum score on the scale is 15, and the maximum score is 75. According to the scores obtained from the scale, a score of 60-75 indicates high psychological well-being, a score of 45-59 indicates moderate psychological well-being, and a score of 15-44 indicates low psychological well-being.

    Time frame: eight weeks

07

Study locations

1 of 1 sites recruiting
  • Ankara University Faculty of Nursing
    Ankara, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07421336
Lead sponsor
Ankara University
Responsible party
Fatma Sena Albayrak (Graduate student, Ankara University) — Principal investigator
First posted
Feb 19, 2026
Start date
Dec 3, 2025
Primary completion
May 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Mar 4, 2026

Study contacts

Fatma Sena Albayrak
Contact
senaalbayrak2976@gmail.com
+90 552-366-2976

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion